Safety of important dermatological drugs (retinoids, immune suppressants, anti androgens and thalidomide) in reproductively active males with respect to pregnancy outcome: A brief review of literature

Simple item page
dc.contributor.authorKumar, Piyushen_US
dc.contributor.authorDas, Anupamen_US
dc.contributor.authorLal, Niharika Ranjanen_US
dc.contributor.authorJain, Sourabhen_US
dc.contributor.authorGhosh, Anupamaen_US
dc.date.accessioned2020-01-02T06:51:21Z
dc.date.available2020-01-02T06:51:21Z
dc.date.issued2018-09
dc.description.abstractPaternally transmitted damage to offspring is recognized as a complex issue. Each parent contributes 23 chromosomes to a child; hence, it is necessary to know the effects of both maternal and paternal pre-and peri-conceptional exposure to drugs on pregnancy outcome. While there are many studies on the effects of maternal drug exposure on pregnancy outcome, literature on paternal exposure is scarce. Of late however, paternal exposure has been receiving increasing attention. We present a brief review on the safety of commonly used drugs in dermatology, focused on retinoids, immune suppressants, anti androgens and thalidomide.en_US
dc.identifier.affiliationsDepartment of Dermatology, Katihar Medical College, Katihar, Bihar, Indiaen_US
dc.identifier.affiliationsDepartment of Dermatology, KPC Medical College and Hospital, Kolkata, West Bengal, Indiaen_US
dc.identifier.affiliationsDepartment of Dermatology, ESI-PGIMSR and ESIC Medical College, Kolkata, West Bengal, Indiaen_US
dc.identifier.affiliationsDepartment of Dermatology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, Indiaen_US
dc.identifier.affiliationsDepartment of Dermatology, CGHS, Kolkata, West Bengal, Indiaen_US
dc.identifier.citationKumar Piyush, Das Anupam, Lal Niharika Ranjan, Jain Sourabh, Ghosh Anupama. Safety of important dermatological drugs (retinoids, immune suppressants, anti androgens and thalidomide) in reproductively active males with respect to pregnancy outcome: A brief review of literature. Indian Journal of Dermatology, Venereology and Leprology. 2018 Sep; 84(5): 539-546en_US
dc.identifier.issn0378-6323
dc.identifier.issn0973-3922
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/192413
dc.languageenen_US
dc.publisherIndian Association of Dermatologists, Venereologists & Leprologistsen_US
dc.relation.issuenumber5en_US
dc.relation.volume84en_US
dc.source.urihttps://dx.doi.org/10.4103/ijdvl.IJDVL_77_17en_US
dc.subjectAntiandrogenen_US
dc.subjectimmunosuppressiveen_US
dc.subjectreproductively active maleen_US
dc.subjectretinoiden_US
dc.subjectsafety of drugsen_US
dc.subjectthalidomideen_US
dc.titleSafety of important dermatological drugs (retinoids, immune suppressants, anti androgens and thalidomide) in reproductively active males with respect to pregnancy outcome: A brief review of literatureen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijdvl2018v84n5p539.pdf
Size:
619.56 KB
Format:
Adobe Portable Document Format
Download
Collections
Indian Journal of Dermatology, Venereology and Leprology